Financial Press Release

Imerys reports results for the first half 2025 showing stable sales on a comparable basis amid US tariff-driven slowdown in global demand

  • H1 2025 sales stable on a comparable basis (organic growth -0.4%), reflecting persistent low industrial activity in Europe and a weaker North American economy; Q2 2025 revenue down vs Q2 2024 on soft volumes and significant depreciation of the US dollar compared to the euro, partly compensated by continued positive pricing
  • H1 2025 adjusted EBITDA at €281 million (16% of sales), up 1.7% vs H1 2024 like-for-like and excluding the contribution of joint ventures

    • supported by price increases, ongoing cost saving initiatives and strong performance of the conductive additives business
    • impacted by lower contribution from JVs, perimeter and currency effects

    Q2 2025 adjusted EBITDA at €154 million, up 1.7% vs Q2 2024 like-for-like and excluding the contribution of JVs

  • Full year 2025 adjusted EBITDA target between €540 and €580 million assuming no material deterioration in the current economic environment
  • Progress update on Emili lithium project